Google+
Jan 15 2016

NSIV Receives one of 4 Cleantech Grants under MassCEC IncubateMass Program

by Dale Earl

State energy officials announced today that awards totaling $530,000 will be given to four Massachusetts small business cleantech incubators. North Shore InnoVentures will receive $165,000 over a three-year period. Other awardees include Chesnut Innovation Center (Amesbury), Greentown Labs (Somerville), and TechSandBox (Hopkinton).

Read more

Jan 15 2016

Quad Technologies Collaborates with UMass Medical School to Highlight Benefits of Novel Cell Separation Solution

by Dale Earl

Quad Technologies has partnered with the University of Massachusetts Medical School in a study  to evaluate the performance of its novel cell separation technology for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.

Read more

Jan 13 2016

TerraVerdae Expands its Elastomeric PHA Biomaterials Portfolio by Strategic Partnership with PolyFerm Canada

by Dale Earl

TerraVerdae announced yesterday that it has entered into a new partnership expanding its product and technology portfolio into the high growth market of biodegradable thermoelastomers. PolyFerm has developed the only line of biodegradable thermoelastomers made entirely from renewable feedstocks. According to CEO and founder William Bardosh, this portfolio addition “opens up significant opportunities in new, high-growth markets.

Read more

Nov 09 2015

InsomniSolv Featured at MassMEDIC’s MedTech Showcase

by Dale Earl

InsomniSolv, a NSIV Biotech member, presented its technology for the treatment of insomnia at the annual MA Medical Device Industry Council MedTech Showcase in Waltham, MA. Over 300 medtech investors and medical device business leaders gathered to hear from 23 startups. InsomniSolv was featured in the press release describing the event.

Read more

Nov 05 2015

TerraVerdae BioWorks pumps up PHA production with a green-friendly process

by Dale Earl

Microbeads: A Green Alternative -TerraVerdae  BioWorks gears up for production using a proprietary process that successfully produces non-petroleum-based plastics that safely biodegrade.

Read more

Nov 05 2015

Quad Technologies Launches Fully Releasable Cell Separation Solution

by Dale Earl

Quad Technologies Inc (“Quad”), developer of a novel cell separation technology, has secured a substantial amount of capital from its Series A round to accelerate development of disruptive cell processing technologies for translational medicine applications. The investment has enabled Quad to launch its MagCloudz™ Streptavidin Cell Separation Kit, which is the first commercially available product incorporating its proprietary QuickGel™ technology.

Read more

Oct 08 2015

NSIV on hand to welcome Applied Photophysics

by Dale Earl

Applied Photophysics, a U.K.-based life sciences company recently opened a demonstration lab to showcase their new line of high performance spectrometers at the Cummings Center in Beverly. 

Read more

Sep 21 2015

Interview at MedCity CONVERGE features Windgap Medical’s CEO

by Dale Earl

Hear more about Windgap Medical’s development of an innovative new product that aims to be a smaller more efficient epinephrine auto-injector to compete with EpiPen.

Read more

Aug 20 2015

Thrive Bioscience Raises $4.0 Million Seed Round

by Dale Earl

Thrive Bioscience Raises $4.0 Million Seed Round to Accelerate Product Development

Read more

Jul 22 2015

Cellanyx Featured in Boston Business Journal

by Dale Earl

How has Cellanyx Captured the BBJ’s Attention?

Read more